STKH

Business Context and Reporting Period

This Form 6-K filing by Steakholder Foods Ltd. covers the month of February 2025, with specific transactions dated February 27 and February 28, 2025. The Company, a foreign private issuer based in Israel, entered into significant capital raising agreements with Alumni Capital, LP to secure immediate funding and establish a future liquidity facility.

Key Financial Metrics and Transaction Details

The filing details a private placement and an equity line of credit rather than standard operating financial results.

• Private Placement: Sale of 192,660 ADSs at $1.269 per ADS.
• Warrants Issued:
  • ADS Warrants: Up to 985,028 ADSs with an exercise price of $2.00.
  • Pre-Funded Warrants: Up to 792,368 ADSs with an exercise price of $0.0001 (immediately exercisable).
• Equity Line of Credit (ELOC): An $8 million commitment (ATMOA) allowing the Company to sell ADSs to the Investor at its discretion.
• Commitment Fee: 2% of the $8 million commitment amount ($160,000), payable in cash or ADSs upon the effectiveness of the ELOC registration statement.
• ELOC Pricing: Purchase price equals 94% of the lowest VWAP of the five business days prior to closing.
• Ownership Limit: Beneficial ownership capped at 4.99% for the Investor.

Material Changes and Unusual Items

The primary material change is the execution of the Share Purchase Agreement and the Any Market Purchase Agreement (ATMOA). These transactions represent a shift in capital structure through the issuance of new equity and warrants. The filing includes a "true-up" provision: if the lowest daily VWAP over five trading days following the SEC's declaration of the resale registration statement is lower than the initial purchase price ($1.269), the Company must issue additional ADSs or Pre-Funded Warrants to the Investor to adjust the effective price.

Guidance, Outlook, and Risks

Outlook and Timeline:

• Closing of the initial purchase is expected on or about February 28, 2025.
• The Company must file a resale registration statement within 5 business days of the agreement and seek effectiveness within 90 days.
• The ELOC term runs until June 30, 2026, or until the $8 million commitment is fully utilized.

Risks and Contingencies:

• Dilution: The issuance of ADSs, Pre-Funded Warrants, and potential future sales under the ELOC will dilute existing shareholders.
• Registration Risk: The ability to utilize the ELOC is contingent on the SEC declaring the ELOC Registration Statement effective.
• Market Price Risk: The ELOC pricing mechanism (94% of VWAP) and the true-up provision expose the Company to potential additional issuance costs if the stock price declines.

Management Commentary: The filing does not contain explicit management commentary on operational performance, focusing solely on the terms of the financing agreements.

Investor Verification Checklist

• Verify the exact closing date and total gross proceeds from the initial private placement.
• Confirm the filing status and expected effectiveness date of the Resale Registration Statement and ELOC Registration Statement with the SEC.
• Monitor the Company's stock price to assess the potential trigger for the "true-up" provision and the impact on share count.
• Review the Company's cash position post-closing to determine immediate liquidity improvements.
• Check for any subsequent filings regarding the utilization of the $8 million ELOC.